SCHEMBL17827623

SCHEMBL17827623

CC(C)(C)n1c2ccccc2c2ccc3c4ccccc4n(C(C)(C)C)c3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.44
ALKBH5 Q6P6C2 1/20 0.42
FTO Q9C0B1 1/20 0.42
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
KIF11 P52732 1/20 0.38
POLB P06746 2/20 0.38
HSP90AA1 P07900 1/20 0.38
IDO1 P14902 1/20 0.38
KDM4E B2RXH2 6/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 1/20 0.37
MAPT P10636 6/20 0.33
PER2 O15055 1/20 0.33
CRY1 Q16526 1/20 0.33
CRY2 Q49AN0 1/20 0.33
CYP19A1 P11511 1/20 0.33
BACE1 P56817 2/20 0.32
ALDH1A1 P00352 4/20 0.32
HPGD P15428 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15128413 0.91 GPR3 (0.42) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL19735298 0.87 HPRT1 (0.40) GPR3ALKBH5FTOCYP1A2KIF11
SCHEMBL15447647 0.86 KDM4E (0.53) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL29625463 0.86 GPR3 (0.52) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL2608424 0.86 GPR3 (0.52) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL17827621 0.85 GPR3 (0.36) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL30005420 0.85 ALKBH5 (0.43) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL24703557 0.84 ALKBH5 (0.59) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL18381750 0.84 GPR3 (0.50) GPR3ALKBH5FTOCYP1A2CYP2C19
SCHEMBL18119023 0.82 KDM4E (0.38) GPR3ALKBH5FTOCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957280-B2 Luminescent compound and electroluminescent device exhibiting thermally activated delayed fluorescence SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20160168162-A1 LUMINESCENT COMPOUND AND ELECTROLUMINESCENT DEVICE EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168162-A1 LUMINESCENT COMPOUND AND ELECTROLUMINESCENT DEVICE EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE OCIAD2, OCIAD1, JUND GPR3 1532/4885ALKBH5 1132/4885FTO 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.